Gold Nanoparticles as Radiosensitizers in Cancer Radiotherapy
Open accessThe DOI matches its Crossref record; 216 of the 216 references it cites were found in a registry or an index.
Abstract
The rapid development of nanotechnology offers a variety of potential therapeutic strategies for cancer treatment. High atomic element nanomaterials are often utilized as radiosensitizers due to their unique photoelectric decay characteristics. Among them, gold nanoparticles (GNPs) are one of the most widely investigated and are considered to be an ideal radiosensitizers for radiotherapy due to their high X-ray absorption and unique physicochemical properties. Over the last few decades, multi-disciplinary studies have focused on the design and optimization of GNPs to achieve greater dosing capability and higher therapeutic effects and highlight potential mechanisms for radiosensitization of GNPs. Although the radiosensitizing potential of GNPs has been widely recognized, its clinical translation still faces many challenges. This review analyses the different roles of GNPs as radiosensitizers in cancer radiotherapy and summarizes recent advances. In addition, the underlying mechanisms of GNP radiosensitization, including physical, chemical and biological mechanisms are discussed, which may provide new directions for the optimization and clinical transformation of next-generation GNPs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“High-Z nanoparticles enhance ROS generation by increasing local energy deposition and secondary electron emission, thereby amplifying free radical formation and oxidative stress following irradiation [9,10,86,88,102,103].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [9]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Nanoparticle-mediated radiosensitization has emerged as a promising strategy to enhance the therapeutic index of irradiation by combining physical dose amplification with biological, microenvironmental, and immunological modulation.”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [9]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Early studies predominantly focused on high-atomic-number (high-Z) materials, including gold, silver, gadolinium, and hafnium-based nanoparticles, with the primary objective of maximizing radiation energy deposition and secondary electron generation [9,85,95,96].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [9]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In general, materials with higher atomic numbers exhibit greater photoelectric interaction probabilities and therefore greater potential for secondary electron generation and local dose enhancement, particularly at kilovoltage photon energies [9,10,84,85,86].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [9]
The cited source says what the claim attributes to it.
In the citing paper
“High-atomic-number (high-Z) nanomaterials interact differently with kilovoltage and megavoltage photon beams, influencing photoelectric absorption, secondary electron generation, and local energy deposition—the principal physical mechanisms underlying nanoparticle-mediated radiotherapy enhancement [9,10,85,86,88].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Nanoparticle Mediated Tumor Vascular Disruption: A Novel Strategy in Radiation Therapy
Kunjachan, S., Detappe, A., Kumar, R., Ireland, T., Cameron, L., Biancur, D. E., Motto-Ros, V., Sancey, L., Sridhar, S., Makrigiorgos, G. M., et al. (2015) · Nano Letters · doi:10.1021/acs.nanolett.5b03073 · Cited by 152
RetractedCisplatin in cancer therapy: Molecular mechanisms of action
Dasari, S., & Bernard Tchounwou, P. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.07.025 · Cited by 5,537
New Perspectives in Cell Adhesion: RGD and Integrins
Ruoslahti, E., & Pierschbacher, M. D. (1987) · Science · doi:10.1126/science.2821619 · Cited by 4,865
Cedervall, T., Lynch, I., Lindman, S., Berggård, T., Thulin, E., Nilsson, H., Dawson, K. A., & Linse, S. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608582104 · Cited by 3,281
Cell-cycle checkpoints and cancer
Kastan, M. B., & Bartek, J. (2004) · Nature · doi:10.1038/nature03097 · Cited by 2,836
Chitin and Chitosan Preparation from Marine Sources. Structure, Properties and Applications
Younes, I., & Rinaudo, M. (2015) · Marine Drugs · doi:10.3390/md13031133 · Cited by 2,562
Progress and challenges towards targeted delivery of cancer therapeutics
Rosenblum, D., Joshi, N., Tao, W., Karp, J. M., & Peer, D. (2018) · Nature Communications · doi:10.1038/s41467-018-03705-y · Cited by 2,220
The Tumour Microenvironment after Radiotherapy: Mechanisms of Resistance and Recurrence
Barker, H. E., Paget, J. T. E., Khan, A. A., & Harrington, K. J. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3958 · Cited by 2,144
Nanoparticle PEGylation for Imaging and Therapy
Jokerst, J. V., Lobovkina, T., Zare, R. N., & Gambhir, S. S. (2011) · Nanomedicine · doi:10.2217/nnm.11.19 · Cited by 2,046
The use of gold nanoparticles to enhance radiotherapy in mice
Hainfeld, J. F., Slatkin, D. N., & Smilowitz, H. M. (2004) · Physics in Medicine and Biology · doi:10.1088/0031-9155/49/18/n03 · Cited by 1,638
Research works printed but not linked: 9
- Shrestha, 2016, Jacobs J Radiat Oncol, 3, 026
- Linam, 2015, Anticancer Res, 35, 2479
- Babaei, 2014, Nanomed J, 1, 211
- Mousavie Anijdan, 2013, Int J Mol Cell Med, 2, 118
- Eblan, 2013, Transl Cancer Res, 2, 320
- Jóźwiak, 2012, Postepy Hig Med Dosw, 66, 165
- Hu, 2015, Int J Nanomed, 10, 2065
- Kalmouni, 2019, Cell Mol Life Sci, 76, 2171
- Daniels, 2017, Biochem Biophys Rep, 10, 62
Cited by
Items 301–339 of 339
He, Z., Li, W., Zhao, Q., Hao, D., Zhong, R., Wang, H., Zhang, X., Du, L., Wu, X., & Liu, J. (2026) · International Journal of Pharmaceutics X · doi:10.1016/j.ijpx.2026.100495
Olaosun, A. M., Aborisade, C. A., Abe, A., Shian, D. E., & Osuolale, P. T. (2026) · Nuclear Science and Engineering · doi:10.1080/00295639.2026.2620960
Söğüt, F., Us, S. B., Demirbağ, H. O., Yilmaz, S. N., & Çömelekoğlu, Ü. (2026) · Radiation Physics and Chemistry · doi:10.1016/j.radphyschem.2026.113819
Moro, S. (2023) · theses.fr (ABES) · doi:10.70675/448ebcaezb632z4399z9621z6dd72997c343 · Cited by 1
Nanotechnology in Cancer Therapy: Small Wonders, Big Magic
Arora, K., Sharma, U., Dubey, S., Sapra, R., & Jain, S. (2026) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9798898814144126010010
Binelli, L., Attili, A., Venditti, I., Battocchio, C., Dini, V., Calcagni, M. L., Ranaldi, M., Iucci, G., Tortora, L., Grande, S., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27104514
Beyond conventional therapies: immunotherapeutic strategies targeting HPV-associated cervical cancer
Patra, S., Shand, H., & Ghorai, S. (2026) · Immunotherapy · doi:10.1080/1750743x.2026.2679883
Pandey, S., Bakshi, V., Yadav, P., Pathak, B., Bajpai, A., & Abdullah, S. (2026) · Next research. · doi:10.1016/j.nexres.2026.101910
Goodarzi, H., Amini, S. M., Koosha, F., & Mohammadi, M. (2026) · Journal of Nanoparticle Research · doi:10.1007/s11051-026-06607-z
Metal–Phenolic Coatings Enable Universal Design of Spherical Nucleic Acids
Chen, C., Luo, T., Zhang, Y., Liu, X., Zhang, H., & Mirkin, C. A. (2026) · Angewandte Chemie International Edition · doi:10.1002/anie.7693760 · Cited by 1
Metal–Phenolic Coatings Enable Universal Design of Spherical Nucleic Acids
Chen, C., Luo, T., Zhang, Y., Liu, X., Zhang, H., & Mirkin, C. A. (2026) · Angewandte Chemie · doi:10.1002/ange.7693760 · Cited by 1
Li, P., Wang, X., He, S., & Ma, H. (2026) · MedComm – Biomaterials and Applications · doi:10.1002/mba2.70058
Review, A. M. A. R. (2026) · Annual Methodological Archive Research Review · doi:10.5281/zenodo.21234569
Gahbiche, O., Ajjel, R., Chiba, E., Marzouki, R., & Mezni, A. (2026) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2026.115999
Li, X., Zhang, F., Kong, X., Li, X., Zhang, Y., & Cui, W. (2026) · Advanced Functional Materials · doi:10.1002/adfm.77045
siRNA–polymer conjugates for the delivery of RNAi therapeutics for the treatment of colon cancer
Belavadi, S., Paul, S., Kadiri, S. K., & Tiwari, P. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-40443-6.00013-1
Zhu, H., Peng, X., Li, J., Zhao, S., Liu, Y., Zheng, L., Fan, J., Cao, H., Zhang, J., & Zhou, S. (2026) · Materials Today Advances · doi:10.1016/j.mtadv.2026.100907
Mohammadi, A., Naderlou, S., Zareian, D. A., Kazemi, F., Sharafi, A., & Danafar, H. (2026) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2026.108801 · Cited by 1
Hani, U., Hamod, M. A., Hamood, N. A., Alhamhoom, Y., Ghazwani, M., Alqahtani, F., Helal, H. A., & Osmani, R. A. M. (2026) · Pharmaceuticals · doi:10.3390/ph19081273 · Cited by 1
Díaz‐Torres, R., Denise, L.-B. L., Ramón, M.-R. J., & Patricia, R.-N. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-36692-5.00007-6
Gold Nanoparticle-Mediated DNA Damage Under FLASH Electron-Beam Irradiation: A Monte Carlo Study
Kim, C. D., & Chow, J. C. L. (2026) · Nanomaterials · doi:10.3390/nano16171116
Mandal, S., Majee, K., Jagdale, A. S., Sharma, G. K., Kunwar, A., & Singh, B. G. (2026) · Chemical Engineering and Processing - Process Intensification · doi:10.1016/j.cep.2026.111039
Vadi, A., Jahan, A., Rehman, U., Abourehab, M. A. S., Gupta, G., Goh, K. W., & Kesharwani, P. (2026) · Journal of drug targeting · doi:10.1080/1061186x.2026.2737278
Kouri, M. A., Kalkou, M.-E., Platoni, K., Kollaros, N., Zourari, K., Chalkia, M., Patatoukas, G., Spathis, A., Kouloulias, V., & EFSTATHOPOULOS, E. P. (2026) · Cancers · doi:10.3390/cancers18183025
Pozdniakova, N. V., & Generalov, E. A. (2026) · Macromol—A Journal of Macromolecular Research · doi:10.3390/macromol6040082
Magnetic Nanomedicine for Cancer: Mechanisms, Modalities, and Translation
Kadam, S., Sonavale, R. M., Das, R., Pawar, J., Shukla, N., Li, Z., Pathade, G. R., Kushwaha, N., Patel, A., Jadhav, S. A., et al. (2026) · Nano Select · doi:10.1002/nano.70190
Small, K., Korysko, P., Gilardi, A., Tangari, G., Farabolini, W., Corsini, R., & Jones, R. M. (2026) · Physica Medica · doi:10.1016/j.ejmp.2026.107177
Aghaei, A., Shaterian, M., Danafar, H., Likozar, B., Šuligoj, A., Gyergyek, S., & Pashaei, B. (2026) · Research Square · doi:10.21203/rs.3.rs-10681885/v1
Nanotecnología y Sociedad en Argentina : regiones del conocimiento tecnocientífico
Berger, M., Carroza, T., Bailo, G. L., Hubert, M., L’hoste, A. S., Burton, B., Sánchez, R. D., Enríquez, S., Agüero, F., Rossi, N. A., et al. (2023) · Repositorio Digital de la UNC (National University of Cordoba)
Nanoparticle-Based Cancer Therapeutics: From Synthesis to Clinical ApplicationsPreprint
Chan, G. (2026) · doi:10.58445/rars.4249
Gold Nanoparticle Shape and Protein Corona Effects on Radiosensitization in Neuroblastoma Cells
Saimuang, K., Jangpatarapongsa, K., Wanotayan, R., Polpanich, D., Jaikuna, T., Yudech, P., Gärtling, L., Oberländer, J., Landfester, K., & Mailänder, V. (2026) · ACS Applied Nano Materials · doi:10.1021/acsanm.6c02756
Nanotechnology-Based Theranostic Strategies for Triple-Negative Breast Cancer
Yang, L., Wang, T., Wu, Y., Zhuang, R., Zhao, W., Li, X., Tu, H., Wang, J., Zu, X., & Li, J. (2026) · ACS Applied Bio Materials · doi:10.1021/acsabm.6c01549
Finogenova, Y. А., Skribitsky, V. А., Lipengolts, A. A., Pozdniakova, N. V., Shpakova, K. E., Tikhonowski, G. V., Kasianov, A. A., Popov, A. A., Smirnova, A. V., Klimentov, S. M., et al. (2026) · ACS Omega · doi:10.1021/acsomega.5c11816
Metadata
- Authors
- Chen, Y., Yang, J., Fu, S., & Wu, J.
- Affiliations
- Southwest Medical University (CN)
- Corresponding author
- Fu, Shaozhi
- Venue
- International Journal of Nanomedicine
- Publisher
- Informa UK Limited
- Published
- 2020-11
- Volume
- Volume 15
- Pages
- 9407-9430
- ISSN
- 1176-9114 (ISSN-L)
- 1178-2013
- PMC
- PMC7699443
- OpenAlex
- W3108978735
- Cited by
- 319
- References
- 216
- Citations by year
- 2026: 46 · 2025: 65 · 2024: 62 · 2023: 79 · 2022: 45 · 2021: 22
- FWCI
- 5.11
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Nanomedicine (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
- Funders
- Servier
- Southwest Medical University (2013LZLY-J40, 14JC0144)
- Topics
- Physical Sciences › Physics and Astronomy › Radiation › Radiation Therapy and Dosimetry
- Physical Sciences › Physics and Astronomy › Radiation › Advanced Radiotherapy Techniques
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Keywords
- gold nanoparticles, radiosensitizers, cancer radiotherapy, radiosensitization mechanism, X-ray absorption, nanoparticle design, clinical translation, nanomedicine
- MeSH terms
- Gold, Humans, Neoplasms, Radiation-Sensitizing Agents, Nanomedicine, Metal Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.



